Article
Hepatitis C treatment: an incipient therapeutic revolution.
Trends in molecular medicine - 1 Jun 2014
deLemos Andrew S, Chung Raymond T
Abstract excerpt
An exciting paradigm shift is occurring in the treatment of hepatitis C virus (HCV). We now have the capacity to specifically target therapy to HCV proteins, and thereby directly interrupt the viral life cycle. The first direct-acting antivirals (DAAs), the NS3-4A serine protease inhibitors bocep...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
